New Therapies of Neovascular AMD beyond Anti-VEGF Injections
Neovascular age-related macular degeneration is a leading cause of vision loss among the aging population. The current standard of care to treat neovascular age-related macular degeneration is inhibiting vascular endothelial growth factor (VEGF) through intravitreal injections. Recent studies have d...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-03-01
|
| Series: | Vision |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2411-5150/2/1/15 |